Pulmonary Vascular
-
HI-PEITHO confirms benefit of USCDT in intermediate-risk pulmonary embolism
Investigator Frederikus A. Klok, MD, PhD, said he expects additional evidence to be published in the coming year, which will shape future guidelines and clinical management of patients with intermediate-high risk pulmonary embolism.
-
Advancing postarrest care in the ICU
New evidence suggests prophylactic antibiotics and biomarkers like neuron-specific enolase may help improve prevention and prognostication of cardiac arrest, offering a more proactive approach to postarrest care.
-
Catching decompensation earlier in acute pulmonary embolism
The 2026 AHA/ACC guidelines provide a much-needed physiological road map for the modern pulmonary embolism specialist with the introduction of new classification groups.
-
Navigating PE treatment: What AHA/ACC guidelines recommend
New AHA/ACC guidelines on acute PE care expand the recommended scope of catheter-based interventions for patients at increased risk of clinical deterioration and provide an in-depth discussion of the role of reperfusion therapies to treat PE.
-
Small trial shows lower ARDS rate, mortality with sivelestat following cardiopulmonary bypass
Nicholas Villalobos, MD, said that while sivelestat may not represent a single solution for ARDS, evidence that it can temper the inflammatory cascade is positive.
-
Bringing the ICU to the patient: ECMO transport programs as high-reliability systems
ECMO transport programs represent an evolution toward networked critical care, extending advanced critical care beyond fixed, tertiary care centers.
-
RSV hospitalization increases cardiorespiratory event, COPD exacerbation risk
Caihua Liang, MD, PhD, and Elizabeth Begier, MD, discuss the importance of prevention in light of data showing elevated risk for up to 180 days following the acute infection.
-
Bilateral lung transplant comparable to heart-lung transplant in primary PAH
Recent findings reinforce the widely used strategy of bilateral lung transplantation for most patients with primary PAH who do not have structural heart disease.
-
Sotatercept in pulmonary arterial hypertension
Understanding when to consider sotatercept and how to use it has become a critical part of PAH care.
-
Bridging the gap: Mechanical circulatory support in lung transplantation for PAH
Review the need for ECLS, MCS, and ECMO in patients with PAH who are undergoing lung transplantation.
-
2026 GOLD report provides key updates on COPD exacerbations, case finding
Gerard J. Criner, MD, FCCP, a member of the GOLD Science Committee, said the latest insights aim to improve patient outcomes and bring awareness to treating COPD exacerbations.
-
Hypoxic burden emerges as a key cardiovascular risk marker in pediatric OSA
Investigator Olga Mediano, PhD, said hypoxic burden may more fully capture the physiological consequences of OSA by integrating the frequency, duration, and depth of oxygen desaturation events.
